baber/WOPTO huggingface dataset:
Patent NZ-505143-A (NZ)
Title: Screw with enlarged head portion for plaster board bracing system, and bracing system
Inventor: STANISH ANTON JOHN
IPC: E04H9/02
Filed: 1999-02-09
Abstract: A braced frame structure is disclosed. A screw (11) which can fix plaster board in a braced plaster board lined structure has an enlarged head portion (12) having a diameter (D), which is at least 9.5mm, and preferably at least 10mm, or possibly greater. The screw (11) has a shank (13) which is threaded. The thread of the shank (13) may extend the entire or only part of the length between the head portion (12) and the point (16).
Patent NZ-506595-A (NZ)
Title: A method for treating waste water to reduce its solid content, biological oxygen demand, and nitrogenous content
IPC: C02F3/12
Filed: 1999-03-03
Abstract: Wastewater   treatment  systems  which   utilize   an interacting surge anoxic mix zone for facilitating  nitrogen removal   and   an   aerobic  sequential   batch   reaction, clarification   and   decantation  zone   for   facilitating aeration  for  BOD  removal and nitrate production  for  the surge  anoxic  mix  zone.  Sludge  reduction  may  also   be accomplished by anaerobic recycle.
Patent NZ-509691-A (NZ)
Title: A data conversion system for accessing the Internet from a portable information terminal based on WAP
Inventor: SASAKI HIROSHI
IPC: G06F13/00
Filed: 2001-02-02
Abstract: A data conversion system includes a terminal device (10) belonging to a first communication network, a server device (30) belonging to a second communication network having a protocol different from that of the first communication network and a protocol conversion device (20) provided at a connection point between the first communication network and the second communication network for conducting protocol conversion. The data conversion means (23) for receiving constraint information peculiar to the terminal device (10) is added to a request from the terminal device (10) for obtaining predetermined contents from the server device (30) and converting predetermined contents obtained from the server device (30) into data based on the constraint information. The data conversion means (23) determines whether predetermined contents obtained from the server device (30) are image data or not and when the predetermined contents are image data, converts the predetermined contents into data based on the constraint information.
Patent NZ-512738-A (NZ)
Title: Catalytic process for the preparation of light olefins from methanol in a fluidised bed reactor
Inventor: BIRJEGA RUXANDRA
IPC: C07C1/20
Filed: 1999-01-11
Abstract: A method of preparing light olefins from methanol conversion by using a microspherical SAPO-34 zeolite in matrix as catalyst. This method comprises contacting methanol with a fluidized or moving bed of said catalyst. It is characterised where SAPO-34 zeolite is prepared from alumina, silica and a preformed template tetraethylammonium phosphate.
Patent NZ-513051-A (NZ)
Title: Transdermal drug delivery system containing the skin penetration enhancers crotamiton or diethyltoluamide
Inventor: SOLOMON MONTAGUE CECIL
IPC: A61K47/18
Filed: 1999-11-17
Abstract: A method of preparing a transdermal drug delivery system comprises: a) dissolving a pharmaceutically active substance in a solvent comprising one or more skin penetration enhancers to form a solution of active substance in the skin penetration enhancers at a concentration less than saturation; b) mixing the resultant solution with an adhesive in the form of an aqueous solution or dispersion; c) forming the mixture obtained in step b) into a film on a release liner or backing sheet and d) drying the film at a temperature less than the boiling point of the skin penetration enhancer or enhancers used as solvents in the dissolution step a). The skin penetration enhancer can be crotamiton or diethyltoluamide.
Patent NZ-517223-A (NZ)
Title: A lock having a self latching strike and deadbolt action
Inventor: MIJUKOVIC ZORAN
IPC: E05C3/30
Filed: 2002-02-15
Abstract: A lock assembly for a sliding door includes a lock 10 and a striker 11.  The rotating hook bolts 13, 14 of the lock can be engaged behind the sliding latch plates 31, 32 of the striker to lock the lock to the striker.  The spring 28 biases the latch plates to the locking position though the plates can be slid to a free position to release the bolts.  A deadlock 20 deadlocks the latch plates against movement when the lock and striker are adjacent each other and prevents the latch plates from moving to the free position.
Patent NZ-518560-A (NZ)
Title: Interactive system and method for viewing on line advertising
Inventor: SMITH BRETT
IPC: G06Q30/00
Filed: 2000-09-08
Abstract: An online interactive advertising system enables viewing of advertising by a consumer who receives data and/or images over a communication system such as the Internet. The consumer may at their option simultaneously receive advertising. The consumer has a consumer station which communicates with a host having a website. An advertising provider communicates with the host and, when the consumer has elected to do so, with the consumer station via the host. The host sends random invitations to view advertising. These may be in the form of a flashing icon, which requires a response from the consumer. The consumer station receives advertising material without requiring software to be downloaded or installed in it. When the consumer elects to view this advertising, the consumer receives rewards, credits or benefits commensurate with the length of time that the advertising is viewed. The reward may be reimbursement for the costs of the Internet time.
Patent NZ-522289-A (NZ)
Title: Space weather prediction system and method
Inventor: INTRILIGATOR DEVRIE S
IPC: G01W1/10
Filed: 2001-04-18
Abstract: A system for predicting space weather comprises: a source of current solar energetic particle data and a processor capable of accessing the data source. The processor predicts a space weather event based on recognizing a complex pattern in the current solar energetic particle data. The pattern is derived from three or more historical solar energetic particle measurements. A system for predicting space weather comprises first and second prediction/identification modules. Each module comprising a system that generates space weather related output data based upon input data, and including data specifying a set of starting conditions specifying when the system is to function. At least one of the starting conditions for the second prediction/identification module is derived from the output data of the first prediction/identification module. A processor-based space weather notification system comprises: a source of predictions and identifications of space weather condition; a notification module including user data specifying a user's susceptibilities to space weather events, means for receiving the predictions and identifications of the space weather conditions, data specifying notification rules for actions to be performed in response to the received predictions and identifications of space weather conditions and means for performing the actions specified in the notification rules thereby notifying the user of the received predictions and identifications of space weather conditions.
Patent NZ-523686-A (NZ)
Title: Antimicrobial agent
Inventor: ELSSER DIETER
IPC: A61L2/00
Filed: 2001-09-27
Abstract: An antimicrobial composition comprising a cyclic compound having Formula I or a derivative thereof, wherein R1 and R2 are independently selected from -OH, =O and OR' wherein R' is H or -COR" and R" is C1-10 alkyl; wherein R3 is a substituent comprising an -OH group; wherein R4 and R5 are each independently selected from a hydrocarbyl group, H, OG or =O, or represents a bond with an adjacent atom on the ring of the cyclic compound; provided that said cyclic compound is not Ascopyrone P; a process for preventing and/or inhibiting the growth of and/or killing micro-organisms in a material comprising the step of contacting the material with the antimicrobial composition; and the use of the composition for preventing and/or inhibiting the growth of and/or killing micro-organisms in a material wherein said micro-organism is selected from Listeria, Salmonella, Bacillus, Saccharomyces, Pseudomonas, Clostridium, Lactobacillus, Brochothrix, Micrococcus, Yersinia, Enterobacter and Zygosaccharomyces.
Patent NZ-526984-A (NZ)
Title: Test for Transmissible Spongiform Encephalopathies
Inventor: O'CONNOR MICHAEL
IPC: G01N33/53
Filed: 2002-01-18
Abstract: A method of detecting transmissible spongiform encephalopathies is disclosed, which involves (a) treating a sample of tissue, blood or a blood derivative from a test subject with alcohol and a detergent, (b) adding an agent which degrades normal prion protein (c) adding an agent which denatures abnormal prion protein, (d) adding a prion-specific antibody and (e) detecting binding of the antibody to the sample. Also described is a method of fixing abnormal prion protein to a substrate comprising (a) treating the protein or a sample suspected to contain the abnormal prion protein with alcohol and an anionic detergent and (b) adding a protease, in the presence of the substrate.
Patent NZ-534833-A (NZ)
Title: Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase (HDAC)
Inventor: VAN EMELEN KRISTOF
IPC: A61K31/53
Filed: 2003-03-11
Abstract: Disclosed are piperazinyl, piperidinyl and morpholinyl derivatives of formula (I) wherein the variables R1, R2, Q, X, Y, Z, L, A and t are as defined in the specification. Compounds of this type are useful in treating proliferative diseases.
Patent NZ-538404-A (NZ)
Title: Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
Inventor: ABOUABDELLAH AHMED
IPC: A61K31/4433
Filed: 2003-08-27
Abstract: 1,3-dioxan-2-yl-alkyl-carbamate derivatives of formula (I), their preparation and their use in therapeutics are disclosed, wherein R1 denotes a phenyl or naphthalenyl group which is optionally substituted by one or more halogen atoms or groups hydroxy, cyano, nitro, C1-3-alkyl, C1-3-alkoxy, trifluoromethyl, trifluoromethoxy, benzyloxy, C3-6-cycloalkyl-O- or C3-6-cycloalkyl-C1-3-alcoxy; R2 denotes (i) a group having general formula CHR3CONHR4, wherein R3 denotes a hydrogen atom or a methyl group and R4 denotes a hydrogen atom or group C1-3-alkyl, C3-5-cycloalkyl or (pyridin-4-yl)methyl, (ii) a 2,2,2-trifluoroethyl group, (iii) a (imidazol-2-yl)methyl group, (iv) a (benzimidazol-2-yl)methyl group or (v) a phenyl group which is optionally substituted by one or more halogen atoms or groups cyano, nitro, C1-3-alkyl, C1-3-alkoxy, trifluoromethyl or trifluoromethoxy; and n denotes a number between 1 and 3, said compound taking the form of a base, an acid addition salt, a hydrate or a solvate.
Patent NZ-538596-A (NZ)
Title: Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of cosmetic, cosmetic preparations containing these compounds
Inventor: DOLEZAL KAREL
Filed: 2002-08-01
Abstract: Disclosed is a cosmetic which contains a heterocyclic compound based on N6-substituted adenine of the general formula I wherein: R2 is H, OH, halogen, alkoxy, amino, hydrazo, mercapto, carboxyl, cyano, nitro, amido, sulfo, sulfamido, acylamino, acyloxy, alkylamino, dialkylamino, alkylmercapto, cycloalkyl and carbamoyl, R6 is R6'-X; R6' is substituted phenyl. Cosmetics of this formula are useful for inhibiting ageing and senescence of mammalian epidermal cells such as keratinocytes or fibroblasts.
Patent NZ-540672-A (NZ)
Title: Immersion apparatus, for perishable food items, with endless flight conveyor passing through tube
Inventor: EVANS LIONEL GORDON
Filed: 2005-06-09
Abstract: A tube has inlet and outlet ends and between the ends is provided a region in which liquid can pool. An endless conveyor passes through the tube with one or more flights substantially traversing the full cross-section of the tube. Further details of the apparatus and processes for using the apparatus are disclosed.
Patent NZ-543139-A (NZ)
Title: Novel phosphonic acid compounds as inhibitors of serine proteases
Inventor: GRECO MICHAEL N
IPC: C07F9/38
Filed: 2004-04-14
Abstract: Disclosed is a compound of Formula (II) wherein Y is not present; X is =O; Z is hydrogen; and wherein the rest of the substituents are disclosed within the specification; and isomers, racemates, enantiomers, diastereomers and salts thereof. Also disclosed is the above compound in the preparation of a medicament for treating an inflammatory or serine protease mediated disorder.
Patent NZ-545935-A (NZ)
Title: Method of treating cancer with HDAC inhibitors
Inventor: BACOPOULOS NICHOLAS G
IPC: A61K/
Filed: 2004-08-26
Abstract: Disclosed is the use of suberoylanilide hydroxamic acid (SAHA) of formula (I), for the preparation of a medicament for treatment of mesothelioma or diffuse large B-cell lymphoma.
Patent NZ-546481-A (NZ)
Title: Fungicidal mixtures
Inventor: GROTE THOMAS
IPC: A01N43/90
Filed: 2004-10-07
Abstract: Disclosed is a fungicidal mixture, which mixture comprises 1) the triazolopyrimidine derivative of the formula I and 2) fluazinam of the formula II, in a synergistically effective amount.
Patent NZ-546557-A (NZ)
Title: Therapeutic agent for mesothelioma comprising interleukin-6
Inventor: NISHIMOTO NORIHIRO
IPC: A61P35/00
Filed: 2004-10-15
Abstract: Provided is the use of an anti-interleukin-6 (IL-6) receptor antibody for production of a medicament for treating mesothelioma. Further provided are uses of specified similar antibodies.
Patent NZ-549369-A (NZ)
Title: Gaming methodology and apparatus
Inventor: STOLLERY ANTHONY ROSS GLEN
Filed: 2006-08-21
Abstract: Computer executable instructions for operating a plurality of gaming machines are configured to execute the steps of (i) collecting activity data from a plurality of gaming machines; (ii) determining a trigger condition for a prize pool; (iii) allocating a portion of wagers made by players of the plurality of gaming machines to the prize pool, and (iv) distributing at least a portion of the prize pool as rewards to at least two selected players when the trigger condition is satisfied. The activity data indicates the size of wagers made by players of individual machines.
Patent NZ-550448-A (NZ)
Title: Pyrimidine derivatives for the treatment of abnormal cell growth
Inventor: LUZZIO MICHAEL JOSEPH
IPC: C07D413/14
Filed: 2005-05-02
Abstract: Disclosed is a pharmaceutically acceptable salt of N-methyl-N-(3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-pyridin-2-yl)-methanesulfonamide, and the use of this salt for the treatment of cancer. Also disclosed are compounds of formula 1, and salts, solvates, and hydrates thereof, wherein the substituents are as defined in the specification, and also their use in treating abnormal cell growth such as cancer.
Patent NZ-553475-A (NZ)
Title: Pharmaceutical composition comprising diclofenac
Inventor: MEYER STEPHAN
IPC: A61K9/70
Filed: 2005-10-20
Abstract: Disclosed is a pharmaceutical composition for oral administration in the form of an edible film, which edible film comprises free acid or a diclofenac resinate, at least one film forming polymer (A) and at least one plasticizer (B), and which edible film completely disintegrates in the mouth of a patient in less than 60 seconds. Suitable film forming polymers (A) are hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, cellulose phthalate and mixtures thereof. Suitable plasticizers (B) are glycerol, polyethylene glycol, ethylene glycol, propylene glycol and mixtures thereof.
Patent NZ-554534-A (NZ)
Title: DNA sequences for human angiogenesis genes
Inventor: GAMBLE JENNIFER RUTH
IPC: A61K45/00
Filed: 2002-09-19
Abstract: Disclosed is the use of an antisense nucleic acid molecule, DNAzyme, ribozyme or an antibody, which specifically modulates the expression of the disclosed nucleic acid sequence (SEQ ID NO: 29) in the manufacture of a medicament for treating certain disorders related to angiogenesis. The disorders are cancer, rheumatoid arthritis, diabetic retinopathy, psoriasis and cardiovascular disease. Further uses for SEQ ID NO: 29 are disclosed including genetically modified animals containing such and screening methods for candidate molecules.
Patent NZ-563430-A (NZ)
Title: The use of alkenyl succinic anhydride compounds derived from symmetrical olefins in internal sizing for paper production
Inventor: WARD WILLIAM J
IPC: D21C3/22
Filed: 2006-04-14
Abstract: Disclosed is a method of imparting resistance of paper to penetration by liquids comprising incorporating in the paper a size composition comprising one or more alkenyl succinic anhydride sizing agents prepared from the reaction of maleic anhydride and one or more substantially symmetrical C20-C28 internal olefins (such as 10-eicosene, 11-docosene, 12-tetracosene, 13-hexacosene, 14-octacosene, 9-eicosene, 10-heneicosene, 10-docosene, 11-tetracosene, 11-tricosene, 12-hexacosene, 12-pentacosene, 13-octacosene, 13-heptacosene), or a mixture thereof.
Patent NZ-568482-A (NZ)
Title: Productivity augmenting protein factor, novel cell lines and uses thereof
Inventor: SANDIG VOLKER
IPC: C07K14/01
Filed: 2006-11-08
Abstract: Discloses a method for preparing a non-adenoviral target virus or one or more target protein(s) which is (are) not related to Adenovirus, which method comprises (a) culturing an expression cell obtained by infecting or transfecting a host cell, having stably integrated into its genome a gene coding for a Adenovirus PIX or a functional variant thereof as a heterologous regulator protein, wherein the functional variant is (i) an Adenovirus PIX mutant having one addition, one substitution and/or one deletion of one amino acid with respect to the wild-type Adenovirus PIX protein, or (ii) and Adenovirus PIX protein modified by fusion of (a) further active protein(s) or peptide(s) to said protein, and stably expressing said regulator protein or the functional variant thereof, with a non-adenoviral target virus, or with a vector carrying nucleic acid sequences encoding said virus, or with a vector carrying nucleic acid sequences encoding one or more target protein(s) which is (are) not related to Adenovirus, and (b) isolating the non-adenoviral target virus or the one or more target protein(s) which is (are) not related to Adenovirus.
Patent NZ-571118-A (NZ)
Title: Combination treatment of metabolic disorders
Inventor: VON BORSTEL REID W
IPC: A61K31/33
Filed: 2007-03-05
Abstract: Use of a phenyl ether biologically active agent of formula (I) in the manufacture of a medicament for treatment of a condition selected from the group consisting of insulin resistance syndrome, diabetes including Type I Diabetes and Type II Diabetes, and polycystic ovary syndrome; or for the treatment or reduction in the chance of developing atherosclerosis, arteriosclerosis, obesity, hypertension, hyperlipidaemia, fatty liver disease, nephropathy, neuropathy, retinopathy, foot ulceration or cataracts associated with diabetes; or for the treatment of a condition selected from the group consisting of hyperlipidaemia, cachexia and obesity. Where the substituents are as disclosed in the description and the agent is formulated for administration in combination with a direct PPAR-gamma agonist in a combined amount effective to treat the metabolic condition, and wherein the Compound of Formula I or salt thereof is adapted for administration in an amount that is less than the usual therapeutic dose when administered alone and is from 50 mg to 150 mg per day. Examples of compound of formula (I) include: 4-(3-(2,6-Dimethylbenzyloxy)phenyl)-4-oxobutyric acid; 3-(2,6-Dimethylbenzyloxy)-phenylacetic acid and 4-3-(2,6-Dimethylbenzyloxy)-phenyl)-4(R)-hydroxybutanoic acid.
Patent NZ-571929-A (NZ)
Title: Agent-enriched nanoparticles based on hydrophilic proteins
Inventor: KREUTER JORG
IPC: A61K47/48
Filed: 2007-02-27
Abstract: Disclosed is an active agent-loaded nanoparticles based on a hydrophilic protein or a combination of hydrophilic proteins, wherein said nanoparticles comprise at least one apolipoprotein which is bound to the hydrophilic protein or the hydrophilic proteins, via polyethylene glycol-alpha-maleimide-omega-NHS esters. Also disclosed is the method of producing the active agent loaded nanoparticles and the use of the nanoparticles in the manufacture of a composition to transport active agents across the blood-brain barrier.
Patent NZ-582424-A (NZ)
Title: Beverage container closure
Inventor: KARAM CARL
IPC: A47G19/23
Filed: 2008-06-06
Abstract: A closure 1 for a beverage container comprises a base, a side wall and a substantially circular rim extending around the upper edge of the side wall. The closure 1 comprises a generally circular disc with a periphery constituting a beverage container rim engagement means 2, and a substantially circular gutter 6 formed in the disc and extending a predetermined distance below it. The gutter 6 surrounds a beverage container support 5 that extends from the gutter 6 above the plane of the disc. The gutter 6 and the beverage container support 5 are dimensioned to engage the base and lower edge of the side wall of a like beverage container when the like beverage container is placed on top of the closure 1.
Patent NZ-594112-A (NZ)
Title: Bacteriocin inducer peptides
Inventor: STERN NORMAN J
IPC: A61K38/16
Filed: 2006-12-08
Abstract: Disclosed are signal peptides produced by the bacteriocin-producing bacteria Lactobacillus salivarius, Enterococcus faecium and Streptococcus cricetus, which stimulate the production of bacteriocins in vitro. The producer bacteria are cultured in the presence of inducer bacteria and a signal peptide having a carboxy terminal sequence VKGLT to increase the production of a bacteriocin.
Patent NZ-599598-A (NZ)
Title: Hyperblebbing shigella strains
Inventor: BERLANDA SCORZA FRANCESCO
IPC: A61K39/00
Filed: 2010-09-28
Abstract: Patent No. 599598 Disclosed is a Shigella bacterium which expresses no more than 4 of Tol A, Tol B, Tol Q, Tol R and Pal proteins. Also disclosed is a Shigella bacterium which does not express a Tol R protein. Also disclosed is a Shigella bacterium which expresses Tol A, Tol B, Tol Q, Tol R and Pal proteins, wherein the Tol A, Tol Q, TolR and/or Pal protein (a) is located in the bacterium's inner or outer membrane, and (b) includes one or more amino acid sequence mutation(s) such that, compared to the same bacterium without said mutation(s), the bacterium releases greater quantities of outer membrane blebs when growing in culture medium.
Patent NZ-605057-A (NZ)
Title: A driver related data storage system and method
Inventor: OVELY CYRIL
IPC: G07C5/02
Filed: 2012-12-20
Abstract: Disclosed is a driver related data storage system with a data generation module (103) adapted to generate driver related data, an encryption module (111) adapted to encrypt driver related data and a storage module (113) adapted to store the encrypted driver related data. A code generation module (115) generates a displayable machine readable code (119) based on the stored encrypted driver related data and an output module (117) outputs the generated displayable machine readable code (119).